Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers

**Background:** Understanding patient and caregiver preferences for treatment is important for optimizing treatment decisions. Non-stimulant therapies are an alternative treatment option to stimulant therapy for attention-deficit/hyperactivity disorder (ADHD). Guanfacine extended release (GXR) and a...

Full description

Saved in:
Bibliographic Details
Main Authors: Emuella Flood, Kavita Gajria, Vanja Sikirica, Paul Hodgkins, M. Haim Erder, Frank Lopez, Daniel Connor
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2016-10-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://doi.org/10.36469/9842
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860351690604544
author Emuella Flood
Kavita Gajria
Vanja Sikirica
Paul Hodgkins
M. Haim Erder
Frank Lopez
Daniel Connor
author_facet Emuella Flood
Kavita Gajria
Vanja Sikirica
Paul Hodgkins
M. Haim Erder
Frank Lopez
Daniel Connor
author_sort Emuella Flood
collection DOAJ
description **Background:** Understanding patient and caregiver preferences for treatment is important for optimizing treatment decisions. Non-stimulant therapies are an alternative treatment option to stimulant therapy for attention-deficit/hyperactivity disorder (ADHD). Guanfacine extended release (GXR) and atomoxetine (ATX) are two non-stimulant medications approved in the United States for the treatment of ADHD. **Objective:** To identify non-stimulant ADHD medication attributes important to caregivers/patients. **Methods:** US caregivers of ADHD patients (6–17 years) and child/adolescent patients (10–17 years) completed an adaptive conjoint analysis survey. Respondents selected between hypothetical treatments with different attributes. Ordinary least-squares and hierarchical Bayes regression using Sawtooth Software were used to calculate utilities, importance ratings, and preferences. **Results:** 483 caregivers (mean age: 41.9 years, standard deviation [SD]: 8.7; 75% female) and 211 children/adolescents (mean age: 14.5 years, SD: 2.2; 70% male) completed the survey. Based on importance ratings, the most influential attributes for both caregivers and children/adolescents were chance of somnolence, efficacy, and for caregivers, effect on oppositionality and black box warning. Most caregivers (95.3%) and children/adolescents (93.8%) preferred GXR over ATX. In several sensitivity analyses in which attribute levels varied, GXR remained the preferred medication with the exception of one scenario. **Conclusions:** Children/adolescents and caregivers demonstrated in this study that they can clearly express their preferences for treatment attributes and treatment choices; in this case they preferred GXR to ATX. Patients and caregiver preferences could be useful inputs to the treatment selection decision-making process.
format Article
id doaj-art-7cf2505f2eab4ecdb556b525af8ad5eb
institution Kabale University
issn 2327-2236
language English
publishDate 2016-10-01
publisher Columbia Data Analytics, LLC
record_format Article
series Journal of Health Economics and Outcomes Research
spelling doaj-art-7cf2505f2eab4ecdb556b525af8ad5eb2025-02-10T16:12:42ZengColumbia Data Analytics, LLCJournal of Health Economics and Outcomes Research2327-22362016-10-0131Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their CaregiversEmuella FloodKavita GajriaVanja SikiricaPaul HodgkinsM. Haim ErderFrank LopezDaniel Connor**Background:** Understanding patient and caregiver preferences for treatment is important for optimizing treatment decisions. Non-stimulant therapies are an alternative treatment option to stimulant therapy for attention-deficit/hyperactivity disorder (ADHD). Guanfacine extended release (GXR) and atomoxetine (ATX) are two non-stimulant medications approved in the United States for the treatment of ADHD. **Objective:** To identify non-stimulant ADHD medication attributes important to caregivers/patients. **Methods:** US caregivers of ADHD patients (6–17 years) and child/adolescent patients (10–17 years) completed an adaptive conjoint analysis survey. Respondents selected between hypothetical treatments with different attributes. Ordinary least-squares and hierarchical Bayes regression using Sawtooth Software were used to calculate utilities, importance ratings, and preferences. **Results:** 483 caregivers (mean age: 41.9 years, standard deviation [SD]: 8.7; 75% female) and 211 children/adolescents (mean age: 14.5 years, SD: 2.2; 70% male) completed the survey. Based on importance ratings, the most influential attributes for both caregivers and children/adolescents were chance of somnolence, efficacy, and for caregivers, effect on oppositionality and black box warning. Most caregivers (95.3%) and children/adolescents (93.8%) preferred GXR over ATX. In several sensitivity analyses in which attribute levels varied, GXR remained the preferred medication with the exception of one scenario. **Conclusions:** Children/adolescents and caregivers demonstrated in this study that they can clearly express their preferences for treatment attributes and treatment choices; in this case they preferred GXR to ATX. Patients and caregiver preferences could be useful inputs to the treatment selection decision-making process.https://doi.org/10.36469/9842
spellingShingle Emuella Flood
Kavita Gajria
Vanja Sikirica
Paul Hodgkins
M. Haim Erder
Frank Lopez
Daniel Connor
Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers
Journal of Health Economics and Outcomes Research
title Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers
title_full Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers
title_fullStr Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers
title_full_unstemmed Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers
title_short Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers
title_sort preferences for attention deficit hyperactivity disorder adhd non stimulant treatment characteristics among children and adolescents with adhd and their caregivers
url https://doi.org/10.36469/9842
work_keys_str_mv AT emuellaflood preferencesforattentiondeficithyperactivitydisorderadhdnonstimulanttreatmentcharacteristicsamongchildrenandadolescentswithadhdandtheircaregivers
AT kavitagajria preferencesforattentiondeficithyperactivitydisorderadhdnonstimulanttreatmentcharacteristicsamongchildrenandadolescentswithadhdandtheircaregivers
AT vanjasikirica preferencesforattentiondeficithyperactivitydisorderadhdnonstimulanttreatmentcharacteristicsamongchildrenandadolescentswithadhdandtheircaregivers
AT paulhodgkins preferencesforattentiondeficithyperactivitydisorderadhdnonstimulanttreatmentcharacteristicsamongchildrenandadolescentswithadhdandtheircaregivers
AT mhaimerder preferencesforattentiondeficithyperactivitydisorderadhdnonstimulanttreatmentcharacteristicsamongchildrenandadolescentswithadhdandtheircaregivers
AT franklopez preferencesforattentiondeficithyperactivitydisorderadhdnonstimulanttreatmentcharacteristicsamongchildrenandadolescentswithadhdandtheircaregivers
AT danielconnor preferencesforattentiondeficithyperactivitydisorderadhdnonstimulanttreatmentcharacteristicsamongchildrenandadolescentswithadhdandtheircaregivers